Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles
GCL TECH (03800) spent approximately 451.807 million Hong Kong dollars to repurchase 66.01 million shares on June 29th.
On June 29th, Tuhu-W (09690) spent 2.7591 million Hong Kong dollars to repurchase 224,000 shares.
CHINA IN-TECH (00464) announced its annual performance, with a net loss attributable to shareholders of HK$30.487 million, a decrease of 38.7% year-on-year.
GCL TECH (03800) spent approximately 451.807 million Hong Kong dollars to repurchase 66.01 million shares on June 29th.
On June 29th, Tuhu-W (09690) spent 2.7591 million Hong Kong dollars to repurchase 224,000 shares.
CHINA IN-TECH (00464) announced its annual performance, with a net loss attributable to shareholders of HK$30.487 million, a decrease of 38.7% year-on-year.
RECOMMEND
